Your browser doesn't support javascript.
loading
Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer.
Sugase, Takahito; Sugimura, Keijiro; Kanemura, Takashi; Takeoka, Tomohira; Yamamoto, Masaaki; Shinno, Naoki; Hara, Hisashi; Omori, Takeshi; Fujii, Yoshiaki; Mukai, Yosuke; Mikamori, Manabu; Hasegawa, Shinichiro; Haraguchi, Naotsugu; Akita, Hirofumi; Nishimura, Junichi; Wada, Hiroshi; Matsuda, Chu; Yasui, Masayoshi; Miyata, Hiroshi.
Afiliación
  • Sugase T; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan, takahito.sugase@oici.jp.
  • Sugimura K; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Kanemura T; Department of Gastroenterological Surgery, Kansai Rosai Hospital, Amagasaki, Japan.
  • Takeoka T; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Yamamoto M; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Shinno N; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Hara H; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Omori T; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Fujii Y; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Mukai Y; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Mikamori M; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Hasegawa S; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Haraguchi N; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Akita H; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Nishimura J; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Wada H; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Matsuda C; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Yasui M; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Miyata H; Department of Digestive Surgery, Osaka International Cancer Institute, Osaka, Japan.
Oncology ; 100(12): 655-665, 2022.
Article en En | MEDLINE | ID: mdl-36198297
ABSTRACT

BACKGROUND:

Preoperative chemoradiation therapy (CRT) or chemotherapy (CT) followed by surgery is currently being administered for advanced esophageal cancer. However, few studies have directly compared CRT and CT for treating locally advanced esophageal carcinoma. This study aimed to assess postoperative recurrence patterns and post-recurrence outcomes in patients with radical esophagectomy after CRT or triplet CT regimen with docetaxel, cisplatin, and 5-fluorouracil (DCF).

METHODS:

This study included 325 consecutive patients with thoracic esophageal cancer who received preoperative CRT or DCF followed by curative esophagectomy between January 2010 and December 2019. We compared recurrence patterns after surgery and post-recurrence treatments between CRT and DCF. Locoregional recurrence was defined as recurrences at the primary tumor site or regional lymph nodes. Distant recurrence was defined as non-regional lymph node recurrences, systemic metastases, malignant pleural effusions, or peritoneal metastases.

RESULTS:

Among 325 patients, 74 received preoperative CF + RT and 251 received preoperative DCF. A propensity score-matched cohort of 53 with CRT and 53 with DCF was included. CRT patients had tumors located in the upper esophagus and had more advanced cancer than DCF patients; however, no differences in patient characteristics were observed in the matched cohort. CRT patients had better histopathological responses and control of locoregional recurrence than DCF patients. On the other hand, distant recurrence, especially in the non-regional lymph node, lung, and pleural dissemination, significantly developed more frequently in CRT patients. Furthermore, CRT patients may have received insufficient post-recurrence treatment, owing to fewer treatment options. Therefore, although there was no difference in recurrence rate in the two groups, CRT patients had significantly poorer post-recurrence survival than DCF patients.

CONCLUSIONS:

Preoperative DCF could reduce distant recurrence after surgery compared to preoperative CRT. The differences in recurrence patterns can be related to the selection of post-recurrence treatment and their prognosis after recurrence.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncology Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncology Año: 2022 Tipo del documento: Article